Marco Capozzoli

Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy.

M. Galeazzi, A. Vitale, Claudia Fabiani, 2017, The Israel Medical Association journal : IMAJ.

Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab

M. Galeazzi, A. Vitale, Claudia Fabiani, 2018, Clinical Rheumatology.

Cumulative retention rate of adalimumab in patients with Behçet’s disease-related uveitis: a four-year follow-up study

M. Galeazzi, A. Vitale, Claudia Fabiani, 2017, British Journal of Ophthalmology.

Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study

M. Galeazzi, A. Vitale, Claudia Fabiani, 2017, Internal and Emergency Medicine.

Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis

M. Galeazzi, A. Vitale, Claudia Fabiani, 2018, Clinical Rheumatology.

Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing–remitting multiple sclerosis

M. Fruschelli, P. Annunziata, M. Gelmi, 2019, International Ophthalmology.